Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy

Fig. 2

Clinical courses after HCT in each group of CY/TBI and HDCA/CY/TBI. The cumulative incidence of major clinical events after HCT, such as engraftment, GVHD, infection, and other acute phase complications are summarized. In each event, adjusted HRs in the HDCA/CY/TBI group were analyzed in comparison with the CY/TBI group. Dots indicate HRs, and bars indicate 95 % CI ranges

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us